Project Details
Description
A multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects with Metastic, Locally Advanced,
| Status | Finished |
|---|---|
| Effective start/end date | 9/16/14 → 12/31/18 |
Funding
- CYTRX
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.